Pharming Group reopens EMEA’s CB market
Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: